Skip to main content

Tricuspid Valve Disease clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • TRISCEND II Pivotal Trial

    open to eligible people ages 18 years and up

    Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system

    San Francisco, California and other locations

Our lead scientists for Tricuspid Valve Disease research studies include .

Last updated: